paroxetine has been researched along with cardiovascular agents in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coletta, C; Gerö, D; Módis, K; Oláh, G; Suzuki, K; Szabo, C; Szoleczky, P | 1 |
| Wheatcroft, SB | 1 |
| Cannavo, A; Cheung, JY; Glukhova, A; Homan, KT; Koch, WJ; Larsen, SD; Song, J; Tesmer, JJG; Waldschmidt, HV | 1 |
| Chang, CC; Chang, HA; Huang, SY; Kao, LC; Kuo, TB; Tzeng, NS; Yeh, TC | 1 |
1 trial(s) available for paroxetine and cardiovascular agents
| Article | Year |
|---|---|
Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Blood Pressure; Cardiovascular Agents; Case-Control Studies; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Rest; Severity of Illness Index; Taiwan; Young Adult | 2016 |
3 other study(ies) available for paroxetine and cardiovascular agents
| Article | Year |
|---|---|
Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction.
Topics: Animals; Antidepressive Agents, Second-Generation; Antioxidants; Aorta, Thoracic; Cardiovascular Agents; Cell Line; Cell Nucleus; Cytoplasm; Diabetic Angiopathies; DNA Damage; DNA, Mitochondrial; Endothelium, Vascular; Humans; In Vitro Techniques; Male; Mice; Mitochondria; Oxidative Stress; Paroxetine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors | 2013 |
Teaching an old drug new tricks: can paroxetine ease the burden of cardiovascular disease in diabetes?
Topics: Animals; Antioxidants; Cardiovascular Agents; Diabetic Angiopathies; Endothelium, Vascular; Humans; Male; Paroxetine | 2013 |
Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor.
Topics: Animals; Cardiovascular Agents; Catalytic Domain; Cattle; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; G-Protein-Coupled Receptor Kinase 5; Gene Expression; Heart Septum; Heart Ventricles; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Kinetics; Mice; Models, Molecular; Molecular Sequence Data; Mutation; Myocardial Contraction; Myocytes, Cardiac; Paroxetine; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Pyridines; Sequence Alignment | 2015 |